期刊文献+

脑梗死患者的D-二聚体与梗死亚型及其预后的关系 被引量:16

D-Dimer in ischemic cerebral infarction: association with infarction sub-type, short and long term outcomes.
下载PDF
导出
摘要 目的 探讨脑梗死亚急性期患者的 D-二聚体水平与梗死类型的关系及其近、远期预后价值。方法 对 172例脑梗死患者的血浆 D-二聚体进行了测定。对患者出院时的临床神经功能缺损程度进行评定 ,并观察其出院后再发心血管终点事件及死亡。结果 心源性脑梗死患者的 D-二聚体水平最高、血栓形成性脑梗死患者的 D-二聚体居中、腔隙性脑梗死患者的 D-二聚体水平最低 ,与健康人无显著差异。 D-二聚体水平与出院前的临床神经功能缺损评分直线相关。随访 1.4 5年发现 ,D-二聚体是心血管事件的独立危险因子。D-二聚体水平高于 1.5 1m g/ L 出现心脑血管事件的相对危险度为 1.73,校正后为 1.4 1。结论  D-二聚体与脑梗死的类型有关 。 Objective To investigate the association between plasma D-Dimer with infarction sub-type, short- and long-term predictive value of cardiovascular outcomes in patients with sub-acute cerebral infarction. Methods Plasma D-Dimer was measured in patients with cerebral infarction. The outcomes were evaluated before discharge and in the follow-up. Results The level of plasma D-Dimer was significantlythe highest in the patients with cardioembolic infarction, in the medium with atherothrombotic infarction, the lowest with lacunar infarction, there was nosignificant difference between the patients with lacunar infarction and healthy controls. There was a linear relationship between plasma D-Dimer and neurological function defect score. In a multivariate model, D-Dimer was found to be an independent risk factor associated to total recurrent cardiovascular events over an average of 1.45 years follow-up. The relative risk of D-Dimer more than 1.51 mg/L for the total cardiovascular events was 1.73, and 1.41 after adjustment. Conclusions The plasma D-Dimer in the sub-acute phase is associated with sub-type of cerebral infarction,and is an independent risk factor of recurrent cardiovascular events.
出处 《中国心血管杂志》 2003年第4期263-264,269,共3页 Chinese Journal of Cardiovascular Medicine
关键词 脑梗死 D-二聚体 心源性 心脑血管事件 Cerebral infarction D-Dimer, Cardiogenic Cardiovascular event
  • 相关文献

参考文献8

  • 1脑卒中患者临床神经功能缺损程度评分标准(1995)[J].中华神经科杂志,1996,29(6):381-383. 被引量:15767
  • 2各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33058
  • 3Kataoka S, Hirose G, Hori A,et al. Activation of thrombosis and fibrinolysis following brain infarction[J]. J Neurol Sci, 2000,181:82-88.
  • 4Berge E, Friis P, Sandset PM. Hemostatic activation in acute ischemic stroke[J]. Thromb Res, 2001,101 : 13-21.
  • 5Tohgi H, Kawashima M, Tamura K,et al. Coagula-tion-fibrinolysis abnormalities in acute and chronic phases of cerebral thrombosis and embolism [J].Stroke, 1990,21 : 1663-1667.
  • 6Broderick JP, Phillips SJ, O'Fallon WM, et al. Relationship of cardiac disease tostroke occurrence, recurrence, and mortality [J]. Stroke, 1992,23 ( 9 ) : 1250-1256.
  • 7Tohgi H, Takahashi H, Chiba K, et al. Coagulation-fibrinolysis system in poststroke patients receiving antiplatelet medication [J]. Stroke 1993,24 ( 6 ) : 801- 804.
  • 8Szczeklik A, Krzanowski M, Gora P, et al. Antiplatelet drugs and generation of thrombin in clotting blood[J]. Blood, 1992,80(8) :2006-2011.

共引文献42977

同被引文献138

引证文献16

二级引证文献126

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部